Navigation Links
Bayer's Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
Date:11/8/2012

WAYNE, N.J., Nov. 8, 2012 /PRNewswire/ -- At the National Hemophilia Foundation (NHF) Annual Meeting in Orlando today, Bayer HealthCare, the NHF and Save One Life celebrated the successful conclusion of the second annual Virtual Walk for Hemophilia, an engaging, online contest designed to raise awareness and funds for those living with bleeding disorders.

With an innovative spin on the fundraising walk idea, The Virtual Walk for Hemophilia (www.walkforhemophilia.com) employs a website where people interested in supporting those with hemophilia can virtually "walk" online.  Virtual walkers choose which NHF chapter they support, and create a customized avatar to represent themselves in the virtual walk.  At the time the Virtual Walk ended on November 6th, more than 32,000 people – those with and without hemophilia – had signed up. To put this number in perspective, the total number of people with hemophilia in the U.S. is currently estimated to be 15,000-20,000.

Bayer provided $30,000 in sponsorship funds to the national office of the NHF and an additional $33,500 in sponsorship funds to the five chapters with the greatest number of walkers, for a total of more than $60,000. Virtual walkers also had a chance to double the points they contributed to their chapter, by participating in an actual, physical fundraising walk.  This way, Bayer was able to provide a Virtual Walk, while also supporting chapters' own efforts at hosting fundraising walks throughout the country.

"Bayer's Virtual Walk was an exciting initiative for us this year," said Cindy Komar, Executive Director, Arizona Hemophilia Foundation.  "Encouraging people to sign up for the Walk was a great way for us to engage with our constituents, and it reenergized our whole team.  We're grateful for the sponsorship funds Bayer provided to us, and know that they will help us do even more for the hemophilia community in the coming year."

The chapters receiving sponsorship funds are:

First place: Arizona Hemophilia Association, with 9,004 walkers, received $15,000

Second place: Bleeding Disorders Alliance Illinois, with 8,714 walkers, received $10,000

Third place: Texas Central Hemophilia Association, with 6,833 walkers, received $5,000

Fourth place:  Nevada Chapter, National Hemophilia Foundation, with 3,625 walkers received $2,500

Fifth place: Nebraska Chapter, National Hemophilia Foundation, with 2,083 walkers, received $1,000

In addition to the sponsorship funds going to the NHF and its chapters, Bayer provided $7,000 in sponsorship funds to Save One Life, a non-profit, international organization that offers people and organizations the opportunity to sponsor a child or adult with a bleeding disorder in a developing country. In total, Bayer provided more than $70,000 in sponsorship funds to organizations in the hemophilia community.

According to Leslie Donato, Vice President/General Manager, Hematology, Bayer HealthCare, "In just its second year, The Virtual Walk for Hemophilia has become a fun and important way for the hemophilia community to come together.  We're gratified to see a strong response again this year, and are especially pleased to be able to provide this support to Save One Life and to the NHF and its participating chapters."

About Hemophilia A

Hemophilia A, also known as factor VIII deficiency or classical hemophilia is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the, joints, muscles or internal organs. Approximately 400,000 people around the world have hemophilia. 

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

BAYER® and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statement

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Intended for U.S. media only


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
2. Omeros Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial
3. Cyberonics To Report Fiscal Year 2013 Second Quarter Results And Host Webcast And Conference Call On November 16, 2012
4. Encision Reports Second Quarter of Fiscal Year 2013 Results
5. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
6. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
7. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
8. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
10. Elbit Imaging Ltd. Announces Second Quarter Results for 2012
11. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... The U.S. Food and Drug Administration today ... the risk of cardiovascular death in adult patients with ... "Cardiovascular disease is a leading cause of death ... Jean-Marc Guettier , M.D., C.M., director of the Division ... Drug Evaluation and Research. "Availability of antidiabetes therapies that ...
(Date:12/2/2016)... in the ECG Cables And ECG Leadwires Market owing to ... devices. On the other hand, the Asia-Pacific ... rate during the forecast period. The market players ... plc ( Ireland ), Koninklijke Philips N.V. ( ... ( China ), held major share of the ...
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 02, 2016 , ... Metabolic Code ... to nutraceuticals and help doctors more efficiently manage their practice. Power2Practice is ... software platform for Integrative and Functional Medicine. , The Metabolic Code platform ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 04, 2016 , ... ... new attractive animation styles with unique displacement design elements," said Christina Austin - ... third designs. Choose from a variety of design styles that include both left ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... Responsible dental ... One must brush properly to achieve optimal results. This important necessity inspired an inventor ... need for a way to ensure that people break or avoid bad techniques of ...
(Date:12/2/2016)... Phoenix (PRWEB) , ... December 02, 2016 , ... ... statewide documentary on the perils of heroin that was watched live by 1 ... national Alfred I. duPont-Columbia University Award. , ASU students at the Walter Cronkite ...
Breaking Medicine News(10 mins):